Cyclofluidic

Cyclofluidic is revolutionizing hit and lead optimization using its proprietary closed-loop architecture activity platform, CyclOps™. CyclOps™ integrates chemistry, purification/analysis, screening, and compound design with sophisticated algorithms, enabling drug molecules to be analyzed within minutes of design rather than weeks. Combined with flow chemistry technology developed in Professor Steve Ley’s laboratory at the University of Cambridge, our unique approach tightly integrates synthesis, screening, and molecular design within a single laboratory, allowing for rapid iterative exploration across vast regions of chemical space. CyclOps™ is the leanest approach to cutting-edge discovery, enabling Cyclofluidic to optimize hits in real time, synthesizing and screening only those key compounds that drive the hypothesis toward the best possible lead molecules.